__NUXT_JSONP__("/drugs/Mirdametinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"391210-10-9",chebiId:b,chemicalFormula:b,definition:"An orally bioavailable, synthetic organic molecule targeting mitogen-activated protein kinase kinase (MAPK\u002FERK kinase or MEK) with potential antineoplastic activity. Upon administration, mirdametinib selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK\u002FERK and the inhibition of tumor cell proliferation. The dual specific threonine\u002Ftyrosine kinase MEK is a key component of the RAS\u002FRAF\u002FMEK\u002FERK signaling pathway that is frequently activated in human tumors.",fdaUniiCode:"86K0J5AK6M",identifier:"C52195",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C69145"],synonyms:["MEK Inhibitor PD0325901","MIRDAMETINIB",a,"PD 901","PD-0325901"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FMirdametinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Mirdametinib","","2021-10-30T13:40:34.683Z")));